Brief: FDA Approves New Guardant360 Liquid Cdx, The Largest FDA-Approved Liquid Biopsy Panel With A 100X Expanded Footprint
20/05/2026 13:42
May 20 (Reuters) - Guardant Health Inc GH.O: FDA APPROVES NEW GUARDANT360 LIQUID CDX, THE LARGEST FDA-APPROVED LIQUID BIOPSY PANEL WITH A 100X EXPANDED FOOTPRINT Source text: ID:nBw9W1K8Ma Further company coverage: GH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte